Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Finland.
JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800.
Vitamin D has been associated with a decreased risk of multiple sclerosis (MS) in adulthood; however, some, but not all, previous studies have suggested that in utero vitamin D exposure may be a risk factor for MS later in life.
To examine whether serum 25-hydroxyvitamin D (25[OH]D) levels in early pregnancy are associated with risk of MS in offspring.
DESIGN, SETTING, AND PARTICIPANTS: Prospective, nested case-control study in the Finnish Maternity Cohort conducted in May 2011. We identified 193 individuals with a diagnosis of MS before December 31, 2009, whose mothers are in the Finnish Maternity Cohort and had an available serum sample from the pregnancy with the affected child. We matched 176 cases with 326 controls on region of birth in Finland, date of maternal serum sample collection, date of mother's birth, and date of child's birth.
Maternal serum 25(OH)D levels were measured using a chemiluminescence assay. The risk of MS among offspring and association with maternal 25(OH)D levels were the main outcomes. Conditional logistic regression was used and further adjusted for sex of the child, gestational age at the time of sample collection, and season of sample collection to estimate the relative risks and 95% CIs.
Of the 193 cases in the study, 163 were female. Of the 331 controls in the study, 218 were female. Seventy percent of serum samples were collected during the first trimester of pregnancy. The mean (SD) maternal vitamin D levels were in the insufficient vitamin D range, but higher in maternal control than case samples (15.02 [6.41] ng/mL vs 13.86 [5.49] ng/mL [to convert to nanomoles per liter, multiply by 2.496]). Maternal vitamin D deficiency (25[OH]D levels <12.02 ng/mL) during early pregnancy was associated with a nearly 2-fold increased risk of MS in the offspring (relative risk, 1.90; 95% CI, 1.20-3.01; P = .006) compared with women who did not have deficient 25(OH)D levels. There was no statistically significant association between the risk of MS and increasing serum 25(OH)D levels (P = .12).
Insufficient maternal 25(OH)D during pregnancy may increase the risk of MS in offspring.
维生素 D 与成年人多发性硬化症 (MS) 的发病风险降低有关;然而,一些但不是所有的先前研究表明,胎儿期维生素 D 暴露可能是日后发生 MS 的一个风险因素。
研究妊娠早期血清 25-羟维生素 D(25[OH]D)水平与后代 MS 发病风险之间的关系。
设计、设置和参与者:前瞻性、嵌套病例对照研究,在芬兰母婴队列中进行,于 2011 年 5 月进行。我们在 2009 年 12 月 31 日前确定了 193 名 MS 确诊患者,其母亲为芬兰母婴队列的成员,并且有可用于分析的来自受影响孩子的妊娠血清样本。我们根据在芬兰的出生地区、母亲血清样本采集日期、母亲的出生日期和孩子的出生日期,对 176 例病例和 326 例对照进行了匹配。
使用化学发光法检测母体血清 25(OH)D 水平。后代发生 MS 的风险和与母体 25(OH)D 水平的关系是主要结局。采用条件逻辑回归,进一步调整了孩子的性别、样本采集时的胎龄和样本采集季节,以估计相对风险和 95%置信区间。
在这项研究中,193 例病例中有 163 例为女性。在 331 例对照中,218 例为女性。70%的血清样本采集于妊娠早期。母亲维生素 D 水平平均(SD)处于维生素 D 不足范围,但在母亲对照样本中高于病例样本(15.02 [6.41]ng/mL 比 13.86 [5.49]ng/mL[为了换算成纳摩尔/升,乘以 2.496])。与不缺乏 25(OH)D 的女性相比,妊娠早期母体维生素 D 缺乏(25[OH]D 水平<12.02ng/mL)使后代发生 MS 的风险增加近 2 倍(相对风险,1.90;95%CI,1.20-3.01;P=0.006)。血清 25(OH)D 水平升高与 MS 风险之间无统计学显著相关性(P=0.12)。
妊娠期间母体 25(OH)D 不足可能会增加后代患 MS 的风险。